1. Home
  2. / Science and Technology
  3. / New robot revolutionizes medicine: Technology the size of a GRAIN of rice could transform brain surgeries
reading time 3 min read Comments 0 comments

New robot revolutionizes medicine: Technology the size of a GRAIN of rice could transform brain surgeries

Written by Rafaela Fabris
Published 22/01/2025 às 13:47
New robot revolutionizes medicine: Technology the size of a GRAIN of rice could transform brain surgeries
The new robot is capable of collecting tissue samples from the brain with high precision and without causing significant damage. In addition, it could help in the treatment of diseases such as Parkinson's by safely implanting electrodes.

With an investment of more than 25 million euros, the new robot developed by a French startup promises to revolutionize brain surgeries by minimizing tissue damage and treating diseases such as Parkinson's.

A robot as small as a grain of rice revolutionizing the world of medicine? This is the reality created by French startup Robeauté. With the recent raising of more than 25 million euros, the company has taken a giant step towards transforming brain surgeries, bringing more precision and safety to delicate procedures.

But what makes this innovation so special? Let's explore the details behind this new robot and understand why he promises to change the future of neurosurgery.

The innovation behind the new robot

The robot can move inside the brain to perform biopsies, collecting tissue samples without damaging healthy areas. It can also implant electrodes precisely, helping to treat neurological diseases such as Parkinson's.
The robot can move inside the brain to perform biopsies, collecting tissue samples without damaging healthy areas. It can also implant electrodes precisely, helping to treat neurological diseases such as Parkinson's.

When it comes to brain surgery, precision is everything. Traditional methods, while effective, are often invasive and can cause damage to brain tissue. This is where the magic of Robeauté’s new robot comes in.

Unlike the rigid tools currently used, this microrobot moves smoothly inside the brain, minimizing the risk of injury. It can be used in biopsies, collecting tissue samples without compromising healthy areas, and in the future it could be used as electrodes to treat diseases such as Parkinson's.

Guided by a neurosurgeon, the robot follows pre-defined trajectories and is monitored in real time. It combines cutting-edge technology in electronics, robotics and microfabrication, bringing the most modern technology to operating rooms.

From personal inspiration to cutting-edge technology

Every great innovation is born out of necessity, and the new robot is no exception. The story behind its creation is as inspiring as the technological advancement itself.

Bertrand Duplat, co-founder of Robeauté, decided to develop the technology after experiencing the frustration of not being able to treat his mother’s inoperable brain tumor. It was this personal pain that motivated him to seek a solution that would help other families avoid similar situations.

It took five years of research and collaboration with several laboratories so that the robot could become a reality. From the first successful tests on animal cadavers to more complex experiments on humans, the path was challenging, but full of learning.

Applications and impact in the medical field

The robot’s first application is in brain biopsies, allowing for highly accurate and low-risk tissue collection. This could open the door to faster diagnoses and more effective treatments.

In addition to biopsies, the robot has the potential to revolutionize neurological treatments. It could help implant electrodes, enabling innovative therapies for diseases such as Parkinson's and other conditions that affect the nervous system.

Financing and future prospects

The recent €25 million funding round is a clear sign that the market believes in Robeauté’s potential. With these funds, the startup plans to expand its trials and bring its technology to the world’s largest medical centers.

Although the robot has shown promising results, The big challenge now is to obtain regulatory approvals, such as that from the FDA in the United States. Human trials are expected to begin in 2026, marking the beginning of a new era in neurosurgery.

Be the first to react!
React to article
Registration
Notify
guest
0 Comments
Older
Last Most voted
Feedbacks
View all comments
Rafaela Fabris

He talks about innovation, renewable energy, oil and gas. With over 1.200 articles published in the CPG, he updates daily on opportunities in the Brazilian job market. Suggestions for topics: rafafabris11@gmail.com

Share across apps
0
We would love your opinion on this subject, comment!x